LOC101928649: A Potential Drug Target or Biomarker (G101928649)

Target Name: CTC-338M12.4

NCBI ID: G101928649

CTC-338M12.4

Other Name(s): uncharacterized LOC101928649 | Uncharacterized LOC101928649

LOC101928649: A Potential Drug Target or Biomarker

LOC101928649 is a gene located in chromosome 6, specifically position 338.4. It is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. This molecule is of interest due to its unique structure and the various functions it is known to have in various cellular processes. In this article, we will explore the potential implications of LOC101928649 as a drug target or biomarker.

Structure and Function

The LOC101928649 gene is a non-coding RNA molecule that is approximately 29.8 kilobases (kb) in length. It is located on chromosome 6 and has a unique 5'-end that consists of 11 exons (exons are the parts of a gene that code for proteins) and a 3'-end that consists of 9 exons. The 5'-end of the RNA molecule contains a unique feature, a double-stranded RNA loop, which is composed of four exons (exons are the parts of a gene that code for proteins). This double-stranded RNA loop is a unique feature that is not seen in many RNA molecules.

In addition to the double-stranded RNA loop, LOC101928649 is also known for its ability to interact with various proteins. This interaction is known as RNA-protein interactions, which are an important mechanism by which proteins interact with RNA molecules and regulate various cellular processes. LOC101928649 has been shown to interact with several proteins, including the protein known as HIPK3.

HIPK3 is a protein that is known to play a role in various cellular processes, including cell signaling, DNA replication, and metabolism. It is also known to be a potential drug target for various diseases, including cancer. The interaction between LOC101928649 and HIPK3 suggests that LOC101928649 may be a useful biomarker or drug target in the treatment of various diseases.

Drug Target Potential

The potential drug target for LOC101928649 is based on its interaction with the protein HIPK3. HIPK3 is known to play a role in various cellular processes, including cell signaling, DNA replication, and metabolism. It is also known to be a potential drug target for various diseases, including cancer. The interaction between LOC101928649 and HIPK3 suggests that LOC101928649 may be a useful biomarker or drug target in the treatment of various diseases.

In addition to its potential as a drug target, LOC101928649 may also be a useful biomarker in the diagnosis and prognosis of various diseases. The interaction between LOC101928649 and HIPK3 suggests that LOC101928649 may be involved in various cellular processes that are affected by various diseases. This suggests that LOC101928649 may be a useful biomarker for the diagnosis and prognosis of various diseases.

Biomarker Potential

The potential use of LOC101928649 as a biomarker is based on its interaction with the protein HIPK3. HIPK3 is known to play a role in various cellular processes, including cell signaling, DNA replication, and metabolism. It is also known to be a potential drug target for various diseases, including cancer. The interaction between LOC101928649 and HIPK3 suggests that LOC101928649 may be a useful biomarker for the diagnosis and prognosis of various diseases.

In addition to its potential as a biomarker, LOC101928649 may also be involved in the development

Protein Name: Uncharacterized LOC101928649

The "CTC-338M12.4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CTC-338M12.4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets